{"entity":{"type":"insider","cik":"0001754154","url":"/insider/0001754154","json_url":"/insider/0001754154.json","name":"Giacobello Scott M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2019-02-28","last":"2026-04-17","span_basis":"filed_date"},"name_variants":[{"name":"Giacobello Scott M.","source":"filing","n_filings":8,"first_seen":"2019-02-28","last_seen":"2026-04-17"}],"transactions":[{"id":6115207,"accession":"0001754154-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001754154-26-000010","line_url":"/filing/0001754154-26-000010#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141600.0,"shares_display":"141,600","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":584808.0,"total_display":"584,808.00","total_whole":"584,808","shares_owned_after":295224.0,"shares_owned_after_display":"295,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-17","scope":"insider"},{"id":6115202,"accession":"0001754154-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001754154-26-000010","line_url":"/filing/0001754154-26-000010#line-1","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77000.0,"shares_display":"77,000","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":297220.0,"total_display":"297,220.00","total_whole":"297,220","shares_owned_after":436824.0,"shares_owned_after_display":"436,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"},{"id":6061308,"accession":"0001754154-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001754154-26-000002","line_url":"/filing/0001754154-26-000002#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Whitehawk Therapeutics, Inc.","issuer_ticker":"WHWK","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2594.0,"shares_display":"2,594","price_per_share":3.3096,"price_display":"3.31","price_state":"stated","total_value":8585.1024,"total_display":"8,585.10","total_whole":"8,585","shares_owned_after":28100.0,"shares_owned_after_display":"28,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-10","scope":"insider"},{"id":4050694,"accession":"0001415889-25-006318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-006318","line_url":"/filing/0001415889-25-006318#line-2","is_derivative":false,"issuer_cik":"0001422142","issuer_name":"Aadi Bioscience, Inc.","issuer_ticker":"AADI","issuer_name_source":null,"issuer_url":"/issuer/0001422142","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2806.0,"shares_display":"2,806","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":6594.1,"total_display":"6,594.10","total_whole":"6,594","shares_owned_after":23944.0,"shares_owned_after_display":"23,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-03","scope":"insider"},{"id":2631876,"accession":"0000899243-20-008656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-008656","line_url":"/filing/0000899243-20-008656#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7200.0,"shares_display":"7,200","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":48960.0,"total_display":"48,960.00","total_whole":"48,960","shares_owned_after":88224.0,"shares_owned_after_display":"88,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-17","scope":"insider"},{"id":2132489,"accession":"0000899243-20-006992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006992","line_url":"/filing/0000899243-20-006992#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2220.0,"shares_display":"2,220","price_per_share":8.34,"price_display":"8.34","price_state":"stated","total_value":18514.8,"total_display":"18,514.80","total_whole":"18,515","shares_owned_after":81024.0,"shares_owned_after_display":"81,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2894310,"accession":"0000899243-20-006327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006327","line_url":"/filing/0000899243-20-006327#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3624.0,"shares_display":"3,624","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":33232.08,"total_display":"33,232.08","total_whole":"33,232","shares_owned_after":83472.0,"shares_owned_after_display":"83,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider"},{"id":2894299,"accession":"0000899243-20-006327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006327","line_url":"/filing/0000899243-20-006327#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228.0,"shares_display":"228","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":2090.76,"total_display":"2,090.76","total_whole":"2,091","shares_owned_after":83244.0,"shares_owned_after_display":"83,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider"},{"id":8580700,"accession":"0000899243-19-014293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-014293","line_url":"/filing/0000899243-19-014293#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4224.0,"shares_display":"4,224","price_per_share":14.52,"price_display":"14.52","price_state":"stated","total_value":61332.48,"total_display":"61,332.48","total_whole":"61,332","shares_owned_after":87096.0,"shares_owned_after_display":"87,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-21","scope":"insider"},{"id":8375647,"accession":"0000899243-19-005257","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-005257","line_url":"/filing/0000899243-19-005257#line-4","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":12.46,"price_display":"12.46","price_state":"stated","total_value":44856.0,"total_display":"44,856.00","total_whole":"44,856","shares_owned_after":10584.0,"shares_owned_after_display":"10,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"},{"id":8375642,"accession":"0000899243-19-005257","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-005257","line_url":"/filing/0000899243-19-005257#line-3","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1584.0,"shares_display":"1,584","price_per_share":12.42,"price_display":"12.42","price_state":"stated","total_value":19673.28,"total_display":"19,673.28","total_whole":"19,673","shares_owned_after":14184.0,"shares_owned_after_display":"14,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"},{"id":8375638,"accession":"0000899243-19-005257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-005257","line_url":"/filing/0000899243-19-005257#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754154","owner_name":"Giacobello Scott M.","owner_display_name":"Giacobello Scott M.","owner_url":"/insider/0001754154","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48.0,"shares_display":"48","price_per_share":12.38,"price_display":"12.38","price_state":"stated","total_value":594.24,"total_display":"594.24","total_whole":"594","shares_owned_after":10536.0,"shares_owned_after_display":"10,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001422142","name":"Whitehawk Therapeutics, Inc.","url":"/issuer/0001422142","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":3,"first_seen":"2025-03-03","last_seen":"2026-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001351288","name":"GW PHARMACEUTICALS PLC","url":"/issuer/0001351288","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2019-02-28","last_seen":"2020-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001754154","retrieved_at":"2026-08-22T04:53:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}